Timothy P. Zannes - 10 Jan 2025 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Secretary, EVP, Gen. Counsel
Signature
/s/ Maria Zannes, as attorney-in-fact for Timothy P. Zannes
Issuer symbol
BIAF
Transactions as of
10 Jan 2025
Net transactions value
$0
Form type
4
Filing time
14 Jan 2025, 16:15:20 UTC
Previous filing
24 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +8,641 +19% $0.000000 54,765 10 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025.